Adelphi Group Products provides global in-depth understanding of the dynamics in distinct disease and decision areas to address customised strategic marketing, business intelligence, health outcomes, value and communication issues across the brand lifecycle.

Disease understanding and expertise are critical in ever more challenging therapeutic areas.

Holistic benchmarks of disease are a pre-requisite to define and assess independently the real dynamics of the disease as well as opportunities and the impact of medico-marketing strategies.

Unmet therapeutic needs can be defined and monitored through a thorough evaluation of clinical practice, doctor evaluations and perceptions, patient motivation, level of knowledge and satisfaction.

Market definitions, brand performance and potential rely on precise, measurable and disease-specific indicators.

Our Disease Specific Programmes, or DSPs, provide an integrated approach combining doctor and patient audiences incorporating payor and carer perspectives.

Based on up to 12,000 patients and 1,000 doctors worldwide and repeated at regular intervals, the DSPs constitute a ‘gold standard’ reference in the industry in challenging therapeutic areas such as CNS, pain, inflammatory, cardiovascular, respiratory and metabolic diseases.

Click here for details of all DSP's

Click here for details of what each DSP provides

Click here for DSP cutcomes solutions

Click here for DSP communications solutions